StemCells, a stem cell therapeutics developer, has named Scott Greer to its board of directors.
Greer previously served as chairman of Sirna Therapeutics prior to its acquisition by Merck.
People in the News: Jun 10, 2010
Premium
StemCells, a stem cell therapeutics developer, has named Scott Greer to its board of directors.
Greer previously served as chairman of Sirna Therapeutics prior to its acquisition by Merck.